David H. Li - Apr 7, 2025 Form 4 Insider Report for Ingevity Corp (NGVT)

Role
President & CEO
Signature
David H. Li By: Mavis G. Huger as Attorney-in-Fact
Stock symbol
NGVT
Transactions as of
Apr 7, 2025
Transactions value $
$0
Form type
4
Date filed
4/9/2025, 05:28 PM
Previous filing
Apr 8, 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGVT Common Stock Award $0 +86.7K $0.00 86.7K Apr 7, 2025 Direct F1
transaction NGVT Common Stock Award $0 +31.5K +36.36% $0.00 118K Apr 7, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGVT Employee Stock Option (right-to-buy) Award $0 +177K $0.00 177K Apr 7, 2025 Common Stock 177K $31.73 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan ("2016 OIP"), which will vest ratably in three installments on April 7, 2026, 2027, and 2028.
F2 Grant of RSUs pursuant to the 2016 OIP, which will vest ratably in four installments on April 7, 2026, 2027, 2028, and 2029.
F3 These options are granted pursuant to the 2016 OIP. Such options will vest ratably in four installments on April 7, 2026, 2027, 2028 and 2029.